Elixinol Wellness Ltd Ordinary Shares EXL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EXL is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- A$0.00
- Day Range
- A$0.01–0.01
- 52-Week Range
- A$0.00–0.02
- Bid/Ask
- A$0.01 / A$0.01
- Market Cap
- A$7.81 Mil
- Volume/Avg
- 8.3 Mil / 3.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.33
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.elixinolwellness.com
Valuation
|
Metric
|
EXL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.44 |
Price/Sales | 0.33 |
Price/Cash Flow | — |
Price/Earnings
EXL
Financial Strength
|
Metric
|
EXL
|
|---|---|
Quick Ratio | 0.48 |
Current Ratio | 1.64 |
Interest Coverage | −75.41 |
Quick Ratio
EXL
Profitability
|
Metric
|
EXL
|
|---|---|
Return on Assets (Normalized) | −46.97% |
Return on Equity (Normalized) | −73.08% |
Return on Invested Capital (Normalized) | −62.44% |
Return on Assets
EXL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ztkjqmkz | Sdyh | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Xkvslnrbx | Sxhmwmd | $70.8 Bil | |
HLN
| Haleon PLC ADR | Tzjwsrz | Ylr | $37.7 Bil | |
VTRS
| Viatris Inc | Xlklytrp | Yjgk | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hbzllln | Bgc | $12.5 Bil | |
CTLT
| Catalent Inc | Cjphrwvl | Ngtsgd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Drtcfyfhm | Npbbx | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Wfnpgsl | Skn | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ykycpcyw | Schcnb | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Pzctftjpf | Ngmmd | $2.9 Bil |